iSpecimen Inc. (NASDAQ:ISPC) Short Interest Up 302.4% in February

iSpecimen Inc. (NASDAQ:ISPC) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 119,100 shares, an increase of 302.4% from the February 13th total of 29,600 shares. Approximately 14.5% of the shares of the stock are short sold. Based on an average daily volume of 890,700 shares, the days-to-cover ratio is presently 0.1 days.

Hedge Funds Weigh In On iSpecimen

An institutional investor recently bought a new position in iSpecimen stock. Bridgeway Capital Management LLC acquired a new position in shares of iSpecimen Inc. (NASDAQ:ISPC) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 21,800 shares of the company’s stock, valued at approximately $58,000. Bridgeway Capital Management LLC owned about 2.27% of iSpecimen at the end of the most recent quarter. 13.62% of the stock is currently owned by institutional investors.

iSpecimen Stock Performance

iSpecimen stock opened at $1.34 on Friday. The business’s fifty day moving average is $2.02 and its two-hundred day moving average is $3.07. The firm has a market cap of $1.29 million, a P/E ratio of -0.07 and a beta of 1.65. iSpecimen has a 52 week low of $1.24 and a 52 week high of $11.80.

About iSpecimen

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.